ID

18300

Descripción

Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00493077

Link

https://clinicaltrials.gov/show/NCT00493077

Palabras clave

Versiones (1)
  1. 28/10/16 28/10/16 -
Subido en

28 de octubre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Multiple Sclerosis NCT00493077

Inglés

Eligibility Multiple Sclerosis NCT00493077

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
relapsing-remitting ms according to poser criteria(cdms or lsdms)30 or ms according to mcdonald criteria
Descripción

Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0751967
UMLS CUI [2]
C0026769
disability equivalent to an edss of 6.0 or less at screening
Descripción

EDSS

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0451246
neutralizing antibody titre > 20 and <500 in two consecutive nab tests. one must be from before screening
Descripción

Neutralizing Antibodies Titer | Neutralizing Antibodies Tests Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0475463
UMLS CUI [1,2]
C0475208
UMLS CUI [2,1]
C0475463
UMLS CUI [2,2]
C0392366
UMLS CUI [2,3]
C1265611
previous treatment with either subcutaneous administered interferon-b-1b (betaferon®) or interferon-b-1a (rebif tm) prior to enrolment
Descripción

interferon beta-1b Subcutaneous | Betaferon | Interferon beta-1a Subcutaneous | Rebif

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0244713
UMLS CUI [1,2]
C1522438
UMLS CUI [2]
C0592527
UMLS CUI [3,1]
C0254119
UMLS CUI [3,2]
C1522438
UMLS CUI [4]
C0752980
a priori has been decided to be treated with avonex
Descripción

Avonex

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0594372
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
is nab positive on avonex
Descripción

Neutralizing Antibodies Positive Avonex

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0475463
UMLS CUI [1,2]
C1514241
UMLS CUI [1,3]
C0594372
history of major depression
Descripción

Major Depressive Disorder

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1269683
cardiac insufficiency, cardiomyopathy, significant cardiac dysrhythmia, unstable or advanced ischemic heart disease (nyha iii or iv), or significant hypertension (bp > 180/110 mmhg)
Descripción

Heart failure | Cardiomyopathies | Cardiac Arrhythmia Significant | Myocardial Ischemia Unstable | Myocardial Ischemia Advanced | New York Heart Association Classification | Hypertensive disease Significant | Blood Pressure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018801
UMLS CUI [2]
C0878544
UMLS CUI [3,1]
C0003811
UMLS CUI [3,2]
C0750502
UMLS CUI [4,1]
C0151744
UMLS CUI [4,2]
C0443343
UMLS CUI [5,1]
C0151744
UMLS CUI [5,2]
C0205179
UMLS CUI [6]
C1275491
UMLS CUI [7,1]
C0020538
UMLS CUI [7,2]
C0750502
UMLS CUI [8]
C0005823
renal insufficiency defined as serum creatinine > 1.5 times the upper normal reference limit
Descripción

Renal Insufficiency | Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0201976
any systemic disease that can influence the patient's safety and compliance, or the evaluation of the disability
Descripción

Systemic disease Affecting patient safety | Systemic disease Compliance behavior Limited | Systemic disease Affecting Disability Evaluation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C1113679
UMLS CUI [2,1]
C0442893
UMLS CUI [2,2]
C1321605
UMLS CUI [2,3]
C0439801
UMLS CUI [3,1]
C0442893
UMLS CUI [3,2]
C0392760
UMLS CUI [3,3]
C0231170
UMLS CUI [3,4]
C1261322
women who are pregnant, breast-feeding or have the possibility for pregnancy during the trial. to avoid pregnancy, women have to be postmenopausal, surgical sterile, sexually inactive or practice reliable contraceptives
Descripción

Pregnancy | Breast Feeding | Postmenopausal state | Female Sterilization | Sexual Abstinence | Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0232970
UMLS CUI [4]
C0015787
UMLS CUI [5]
C0036899
UMLS CUI [6]
C0700589
Volver a la parte superior de la página

Similar models

Eligibility Multiple Sclerosis NCT00493077

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis
Item
relapsing-remitting ms according to poser criteria(cdms or lsdms)30 or ms according to mcdonald criteria
boolean
C0751967 (UMLS CUI [1])
C0026769 (UMLS CUI [2])
EDSS
Item
disability equivalent to an edss of 6.0 or less at screening
boolean
C0451246 (UMLS CUI [1])
Neutralizing Antibodies Titer | Neutralizing Antibodies Tests Quantity
Item
neutralizing antibody titre > 20 and <500 in two consecutive nab tests. one must be from before screening
boolean
C0475463 (UMLS CUI [1,1])
C0475208 (UMLS CUI [1,2])
C0475463 (UMLS CUI [2,1])
C0392366 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
interferon beta-1b Subcutaneous | Betaferon | Interferon beta-1a Subcutaneous | Rebif
Item
previous treatment with either subcutaneous administered interferon-b-1b (betaferon®) or interferon-b-1a (rebif tm) prior to enrolment
boolean
C0244713 (UMLS CUI [1,1])
C1522438 (UMLS CUI [1,2])
C0592527 (UMLS CUI [2])
C0254119 (UMLS CUI [3,1])
C1522438 (UMLS CUI [3,2])
C0752980 (UMLS CUI [4])
Avonex
Item
a priori has been decided to be treated with avonex
boolean
C0594372 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Neutralizing Antibodies Positive Avonex
Item
is nab positive on avonex
boolean
C0475463 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C0594372 (UMLS CUI [1,3])
Major Depressive Disorder
Item
history of major depression
boolean
C1269683 (UMLS CUI [1])
Heart failure | Cardiomyopathies | Cardiac Arrhythmia Significant | Myocardial Ischemia Unstable | Myocardial Ischemia Advanced | New York Heart Association Classification | Hypertensive disease Significant | Blood Pressure
Item
cardiac insufficiency, cardiomyopathy, significant cardiac dysrhythmia, unstable or advanced ischemic heart disease (nyha iii or iv), or significant hypertension (bp > 180/110 mmhg)
boolean
C0018801 (UMLS CUI [1])
C0878544 (UMLS CUI [2])
C0003811 (UMLS CUI [3,1])
C0750502 (UMLS CUI [3,2])
C0151744 (UMLS CUI [4,1])
C0443343 (UMLS CUI [4,2])
C0151744 (UMLS CUI [5,1])
C0205179 (UMLS CUI [5,2])
C1275491 (UMLS CUI [6])
C0020538 (UMLS CUI [7,1])
C0750502 (UMLS CUI [7,2])
C0005823 (UMLS CUI [8])
Renal Insufficiency | Creatinine measurement, serum
Item
renal insufficiency defined as serum creatinine > 1.5 times the upper normal reference limit
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Systemic disease Affecting patient safety | Systemic disease Compliance behavior Limited | Systemic disease Affecting Disability Evaluation
Item
any systemic disease that can influence the patient's safety and compliance, or the evaluation of the disability
boolean
C0442893 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C1113679 (UMLS CUI [1,3])
C0442893 (UMLS CUI [2,1])
C1321605 (UMLS CUI [2,2])
C0439801 (UMLS CUI [2,3])
C0442893 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0231170 (UMLS CUI [3,3])
C1261322 (UMLS CUI [3,4])
Pregnancy | Breast Feeding | Postmenopausal state | Female Sterilization | Sexual Abstinence | Contraceptive methods
Item
women who are pregnant, breast-feeding or have the possibility for pregnancy during the trial. to avoid pregnancy, women have to be postmenopausal, surgical sterile, sexually inactive or practice reliable contraceptives
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
C0015787 (UMLS CUI [4])
C0036899 (UMLS CUI [5])
C0700589 (UMLS CUI [6])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial